Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.871
Filtrar
1.
Washington, D.C.; OPS; 2021-11-01. (OPS/NMH/MH/21-0033).
en Español | PAHO-IRIS | ID: phr-55093

RESUMEN

El Fondo Estratégico para Suministros de Salud Pública de la Organización Panamericana de la Salud (Fondo Estratégico) ayuda a asegurar la disponibilidad de los medicamentos esenciales para las enfermedades no transmisibles, incluidos los medicamentos para cuidados paliativos, a un precio competitivo para todos los países. El Fondo Estratégico es un mecanismo integrado de adquisiciones mancomunado, y los productos adquiridos cumplen las normas internacionales de seguridad, eficacia y calidad. En este folleto se presenta información sobre los medicamentos y formulaciones disponibles para las enfermedades no transmisibles mediante el Fondo Estratégico, agrupados por categorías: enfermedades cardiovasculares, diabetes, cáncer, enfermedades respiratorias crónicas y cuidados paliativos. Incluye ejemplos de los descuentos logrados por el Fondo Estratégico para los medicamentos esenciales, con el objetivo de procurar precios competitivos para América Latina y el Caribe.


Asunto(s)
Enfermedades no Transmisibles , Cuidados Paliativos , Diabetes Mellitus , Enfermedades Cardiovasculares , Neoplasias , Enfermedades Respiratorias , Medicina , Medicamentos Esenciales , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias
2.
Washington, D.C.; PAHO; 2021-11-01. (PAHO/NMH/MH/21-0033).
en Inglés | PAHO-IRIS | ID: phr-55092

RESUMEN

The Pan American Health Organization’s Revolving Fund for Strategic Public Health Supplies (Strategic Fund) helps ensure the availability of essential medicines for noncommunicable diseases, including palliative care medicines, at a competitive price for all countries. The Strategic Fund is an integrated pooled procurement mechanism, and the products purchased through the Strategic Fund meet international standards in safety, efficacy, and quality. This brochure presents information on the medications and their formulations available through the Strategic Fund for noncommunicable diseases, summarized by category: cardiovascular diseases, diabetes, cancer, chronic respiratory diseases, and palliative care. The brochure includes examples of price reductions achieved by the Strategic Fund for key essential medicines, ensuring competitive prices for these for Latin America and the Caribbean.


Asunto(s)
Enfermedades no Transmisibles , Medicina , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Cuidados Paliativos , Enfermedades Cardiovasculares , Diabetes Mellitus , Neoplasias , Enfermedades Respiratorias , Medicamentos Esenciales
3.
J Am Board Fam Med ; 34(6): 1189-1202, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34772774

RESUMEN

BACKGROUND: Primary care is crucial to the health of individuals and communities, but it faces numerous structural and systemic challenges. Our study assessed the state of primary care in Virginia to prepare for Medicaid expansion. It also provides insight into the frontline of health care prior to an unprecedented global COVID-19 pandemic. METHODS: We surveyed 1622 primary care practices to understand organizational characteristics, scope of care, capacity, and organizational stress. RESULTS: Practices (484) varied in type, ownership, location, and care for medically underserved and diverse patient populations. Most practices accepted uninsured and Medicaid patients. Practices reported a broad scope of care, including offering behavioral health and medication-assisted therapy for opioid addiction. Over half addressed social needs like transportation and unstable housing. One in three practices experienced a significant stress in 2019, prepandemic, and only 18.8% of practices anticipated a stress in 2020. CONCLUSIONS: Primary care serves as the foundation of our health care system and is an essential service, but it is severely stressed, under-resourced, and overburdened in the best of times. Primary care needs strategic workforce planning, adequate access to resources, and financial investment to sustain its value and innovation.


Asunto(s)
COVID-19 , Pandemias , Accesibilidad a los Servicios de Salud , Humanos , Medicaid , Atención Primaria de Salud , SARS-CoV-2 , Estados Unidos , Virginia
4.
Washington D.C; Organización Panamericana de la Salud; 1 ed; Nov. 2021. 14 p. ilus.
Monografía en Español | LIPECS, MINSAPERÚ | ID: biblio-1344724

RESUMEN

En la presente publicación se detalla la información sobre los medicamentos y formulaciones disponibles para las enfermedades no transmisibles mediante el Fondo Estratégico, agrupados por categorías: enfermedades cardiovasculares, diabetes, cáncer, enfermedades respiratorias crónicas y cuidados paliativos. Incluye ejemplos de los descuentos logrados por el Fondo Estratégico para los medicamentos esenciales, con el objetivo de procurar precios competitivos para América Latina y el Caribe


Asunto(s)
Cuidados Paliativos , Preparaciones Farmacéuticas , Enfermedades Cardiovasculares , Medicamentos Esenciales , Enfermedades no Transmisibles , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Fondo Estratégico
5.
Washington, D.C.; PAHO; 2021-10-14.
No convencional en Inglés | PAHO-IRIS | ID: phr-54995

RESUMEN

The acquisition of antimicrobials without a prescription is a global concern. This practice is thriving in countries that lack adequate legislation or where regulations are not properly enforced. The Pan American Health Organization (PAHO) and its member states in the Region of the Americas approved the Global Action Plan on Antimicrobial Resistance, which recognizes antimicrobial resistance as a threat to global public health that requires a multisectoral response. To tackle antimicrobial resistance, a worldwide change in behavior is needed in terms of how these drugs are used and acquired. National approaches are required to address the indiscriminate use and over-prescription of antimicrobials, and to enforce regulations on prescription and acquisition practices. The objective of this communication handbook is to help communication professionals and health program officials develop strategies to raise awareness and promote the importance of the appropriate use of antimicrobials among different stakeholders; raise public awareness about the importance of obtaining antimicrobials with a prescription in order to achieve multisectoral collaboration to ensure compliance with laws and regulations on this issue; and promote a change in behavior regarding the appropriate use and acquisition of antimicrobials by everyone involved. The target audiences for this handbook are the general population (including adolescents, children, and child caregivers/parents of children), healthcare professionals (including pharmacists and pharmacy staff), and various stakeholders (government officials, professional societies, medical organizations, the private sector, local leaders, and health-influencers, among others).


Asunto(s)
Resistencia a Medicamentos , Farmacorresistencia Microbiana , Medicina , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Gestión de Ciencia, Tecnología e Innovación en Salud , Sistemas de Salud , Salud Pública , Programas Nacionales de Salud
6.
Pan Afr Med J ; 39: 242, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34659615

RESUMEN

Access to appropriate healthcare for children remains a challenge in Botswana, as evidenced by the under five mortality rate and integrated management of childhood illness indicators. Successful implementation of the integrated management of childhood illnesses strategy can drastically reduce child mortality through innovation, national health care worker training coverage, enhanced supervision and use of guidelines.


Asunto(s)
Servicios de Salud del Niño/organización & administración , Atención a la Salud/organización & administración , Accesibilidad a los Servicios de Salud , Botswana , Niño , Servicios de Salud del Niño/normas , Mortalidad del Niño , Preescolar , Atención a la Salud/normas , Personal de Salud/educación , Personal de Salud/organización & administración , Humanos
7.
Enferm. foco (Brasília) ; 12(7, supl 1): 110-114, out. 2021.
Artículo en Portugués | LILACS, BDENF - Enfermería | ID: biblio-1337857

RESUMEN

Objetivo: descrever a experiência da implantação de protocolos de Enfermagem para a ampliação do acesso na atenção primária à saúde, mediante a qualificação da prática clínica do Enfermeiro. Método: estudo descritivo em formato de relato de experiência. O cenário de estudo é o Estado Santa Catarina, tendo como população alvo as Secretarias Municipais de Saúde do Estado. O Coren/SC firmou parceria com a Secretaria Municipal de Saúde de Florianópolis para utilização dos Protocolos de Enfermagem, criando um Programa de Adesão para os municípios. Resultados: Desde a implantação, o programa recebeu 225 solicitações de adesão dentre os 295 municípios catarinenses. Atingiu um total de 135 municípios com os protocolos de enfermagem implantados e 1.708 Enfermeiros capacitados. A oferta de Consultas de Enfermagem onde não havia atendimento do Enfermeiro, ampliação do acesso dos pacientes, com redução significativa de filas de espera, além do aumento das consultas de Enfermagem e resolutividade das mesmas. Conclusão: Os Protocolos de Enfermagem constituem-se como ferramenta primordial para a efetivação do modelo de Atenção Primária no Estado e como inovação e diferencial para as pessoas atendidas. A adesão aos protocolos permite a valorização e o protagonismo da Enfermagem na Atenção Primária. (AU)


Objective: To describe the experience of implementing nursing protocols to expand access to primary health care, through the qualification of nurses' clinical practice. Methods: Descriptive study in experience report format. The study setting is the State of Santa Catarina, with the Municipal Health Secretariats of the State as the target population. Coren/SC signed a partnership with the Municipal Health Department of Florianópolis for the use of Nursing Protocols, creating an Adhesion Program for the municipalities. Results: Since its implementation, the program has received 225 requests for membership among the 295 municipalities in Santa Catarina. It reached a total of 135 municipalities with implemented nursing protocols and 1,708 trained nurses. The offer of Nursing Appointments where there was no care provided by the Nurse, expansion of access for patients, with a significant reduction in waiting lines, in addition to the increase in Nursing appointments and their resoluteness. Conclusion: The Nursing Protocols constitute a primordial tool for the realization of the Primary Care model in the State and as an innovation and differential for the people served. Adherence to protocols allows the enhancement and protagonism of Nursing in Primary Care. (AU)


Objetivo: Describir la experiencia de implementación de protocolos de enfermería para ampliar el acceso a la atención primaria de salud, a través de la calificación de la práctica clínica del enfermero. Métodos: Estudio descriptivo en formato de relato de experiencia. El escenario del estudio es el Estado de Santa Catarina, con las Secretarías Municipales de Salud del Estado como población objetivo. Coren / SC firmó una alianza con el Departamento de Salud Municipal de Florianópolis para el uso de Protocolos de Enfermería, creando un Programa de Adhesión para los municipios. Resultados: Desde su implementación, el programa ha recibido 225 solicitudes de membresía entre los 295 municipios de Santa Catarina. Llegó a un total de 135 municipios con protocolos de enfermería implementados y 1,708 enfermeras capacitadas. La oferta de Citas de Enfermería donde no hubo atención por parte de la Enfermera, ampliación del acceso de los pacientes, con una reducción significativa de las filas de espera, además del aumento de las citas de Enfermería y su resolución. Conclusión: Los Protocolos de Enfermería constituyen una herramienta primordial para la realización del modelo de Atención Primaria en el Estado y como innovación y diferencial para las personas atendidas. La adherencia a los protocolos permite la potenciación y protagonismo de la Enfermería en Atención Primaria. (AU)


Asunto(s)
Enfermería , Atención Primaria de Salud , Protocolos Clínicos , Accesibilidad a los Servicios de Salud
8.
Addict Sci Clin Pract ; 16(1): 51, 2021 08 06.
Artículo en Inglés | MEDLINE | ID: mdl-34362445

RESUMEN

BACKGROUND: The Veterans Health Administration (VHA) is invested in expanding access to medication treatment for opioid use disorder (MOUD) to save lives. Access varies across VHA facilities and, thus, requires implementation strategies to promote system-wide adoption of MOUD. We conducted a 12-month study employing external facilitation that targeted MOUD treatment among low-adopting VHA facilities. In this study, we sought to evaluate the patterns of perceived barriers over 1 year of external implementation facilitation using the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework. METHODS: We randomly selected eight VHA facilities from the bottom quartile of the proportion of Veterans with an OUD diagnosis receiving MOUD (< 21%). The 1-year external implementation intervention included developmental evaluation to tailor the facilitation, an on-site visit, and monthly facilitation calls. Facilitators recorded detailed notes for each call on a structured template. Qualitative data was analyzed by coding and mapping barriers to the constructs in the i-PARIHS framework (Innovation, Recipients, Context). We identified emerging themes within each construct by month. RESULTS: Barriers related to the Innovation, such as provider perception of the need for MOUD in their setting, were minimal throughout the 12-month study. Barriers related to Recipients were predominant and fluctuated over time. Recipient barriers were common during the initial months when providers did not have the training and waivers necessary to prescribe MOUD. Once additional providers (Recipients) were trained and waivered to prescribe MOUD, Recipient barriers dropped and then resurfaced as the facilities worked to expand MOUD prescribing to other clinics. Context barriers, such as restrictions on which clinics could prescribe MOUD and fragmented communication across clinics regarding the management of patients receiving MOUD, emerged more prominently in the middle of the study. CONCLUSIONS: VHA facilities participating in 12-month external facilitation interventions experienced fluctuations in barriers to MOUD prescribing with contextual barriers emerging after a facilitated reduction in recipient- level barriers. Adoption of MOUD prescribing in low-adopting VHA facilities requires continual reassessment, monitoring, and readjustment of implementation strategies over time to meet challenges. Although i-PARIHS was useful in categorizing most barriers, the lack of conceptual clarity was a concern for some constructs.


Asunto(s)
Buprenorfina , Trastornos Relacionados con Opioides , Veteranos , Accesibilidad a los Servicios de Salud , Humanos , Trastornos Relacionados con Opioides/tratamiento farmacológico
9.
Front Public Health ; 9: 713177, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34447738

RESUMEN

Universities have a unique role in the health ecosystem as providers of trained staff and discoverers of health innovations. However, often they sit in silos waiting for their rare blockbuster discoveries to change clinical care or seeing health services simply as future employers of their graduates or clinical trial sites. It is a transactional and targetted relationship. This present case study is of a primary health service Access Health and Community (AccessHC) in Australia and its university partner Swinburne University of Technology. Together they established a Kickstart Program which was to provide seed funding for small joint innovation projects generated by both organisations. One project exemplifies the approach. Swinburne who has a Design School was encouraged through the Kickstart Program to design a clinical waiting room of the future. This project started with a needs analysis. The written report was to inform the design. University staff linked with their internal University animations expertise to better communicate the needs analysis. The "Access me Not" animation was created, unknown to the staff at AccessHC. At initial presentation, the way the animation communicated was not imaginable by AccessHC. "Access me not" was submitted for the 2018 International Design Awards and received an honourable mention. However, the AccessHC staff saw other uses for the approach and contacted Swinburne to design a client journey animation for the newly introduced National Disability Scheme (NDIS). The co design produced an animation of immense help to parents in navigating the scheme for complex and chronic disability care and for AccessHC the scripting served as a framework to develop it new internal NDIS care systems and processes. The Swinburne team is now producing health navigation animations for the State Department of Health and Human Services. The Kickstart Program was an engagement strategy that has produced a set of health communication tools that the health service could not have envisaged and which the University could not have imagined an application. Small low risk seed funding can indeed introduce innovations and create beneficial relationships between health services and universities.


Asunto(s)
Ecosistema , Universidades , Australia , Accesibilidad a los Servicios de Salud , Humanos , Atención Primaria de Salud
10.
Washington, D.C.; OPS; 2021-07-01. (OPS/HSS/SF/21-0007).
No convencional en Español | PAHO-IRIS | ID: phr-54473

RESUMEN

El informe anual del Fondo Estratégico de la OPS correspondiente al 2020 describe los progresos realizados durante el período para ayudar a garantizar el acceso a medicamentos e insumos de salud pública esenciales, al tiempo que se respondía a la pandemia de COVID‑19. En el informe se abarcan diversos aspectos del Fondo Estratégico, como los beneficios ofrecidos, los interesados directos que participan, las ofertas de productos y algunas iniciativas clave. Asimismo, se presentan datos útiles, información, estadísticas y ejemplos de formas en que el Fondo Estratégico ha facilitado la cooperación técnica en toda la Región de las Américas. Este informe tiene por objeto resumir la labor crítica realizada por el Fondo Estratégico en el 2020 y ofrecer información sobre sus principios y objetivos operativos para el fortalecimiento y apoyo a largo plazo de los sistemas de salud de la Región.


Asunto(s)
COVID-19 , Coronavirus , Betacoronavirus , Pandemias , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Equipos y Suministros , Américas
11.
J Am Geriatr Soc ; 69(7): 1763-1773, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34245585

RESUMEN

BACKGROUND: The National Institute on Aging (NIA), in conjunction with the Department of Health and Human Services as part of the National Alzheimer's Project Act (NAPA), convened a 2020 Dementia Care, Caregiving, and Services Research Summit Virtual Meeting Series. This review article summarizes three areas of emerging science that are likely to grow in importance given advances in measurement, technologies, and diagnostic tests that were presented at the Summit. RESULTS: Dr. Cassel discussed novel ethical considerations that have resulted from scientific advances that have enabled early diagnosis of pre-clinical dementia. Dr. Monin then summarized issues regarding emotional experiences in persons with dementia and their caregivers and care partners, including the protective impact of positive emotion and heterogeneity of differences in emotion by dementia type and individual characteristics that affect emotional processes with disease progression. Finally, Dr. Jared Benge provided an overview of the role of technologies in buffering the impact of cognitive change on real-world functioning and their utility in safety and monitoring of function and treatment adherence, facilitating communication and transportation, and increasing access to specialists in underserved or remote areas. CONCLUSIONS: National policy initiatives, supported by strong advocacy and increased federal investments, have accelerated the pace of scientific inquiry and innovation related to dementia care and services but have raised some new concerns regarding ethics, disparities, and attending to individual needs, capabilities, and preferences.


Asunto(s)
Demencia , Necesidades y Demandas de Servicios de Salud/ética , Investigación sobre Servicios de Salud/tendencias , Servicios de Salud para Ancianos/ética , Anciano , Anciano de 80 o más Años , Femenino , Accesibilidad a los Servicios de Salud/ética , Disparidades en Atención de Salud/ética , Humanos , Masculino , National Institute on Aging (U.S.) , Estados Unidos
12.
Health Hum Rights ; 23(1): 129-144, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-34194207

RESUMEN

Human rights frameworks afford everyone the right to health and the right to enjoy the benefits of scientific progress and its applications. Both come together to create state obligations to ensure access to medicines and other health technologies. Though the impact of patents on access to high-quality, affordable medicines and health technologies has been well described, there has been little attention to the impact of trade secrecy law in this context. In this paper, we describe how trade secrecy protection comes into conflict with access to medicines-for example, by preventing researchers from accessing clinical trial data, undermining the scale-up of manufacturing in pandemics, and deterring whistleblowers from reporting industry misconduct. The paper proposes measures to diminish the conflict between trade secrecy and health that are consistent with international law and will advance health without undermining innovation.


Asunto(s)
Accesibilidad a los Servicios de Salud , Derechos Humanos , Comercio , Industria Farmacéutica , Humanos
13.
Glob Heart ; 16(1): 44, 2021 06 10.
Artículo en Inglés | MEDLINE | ID: mdl-34211830

RESUMEN

During the COVI9-19 pandemic, Pakkred hospital in Thailand implemented innovative practices to ensure the continuation of essential medical services for non-communicable disease patients. These practices included decentralized care, telemedicine, home blood pressure monitoring, community delivery of medicines, and facility infrastructure changes. Despite the decrease in hospital visits by hypertension patients during the pandemic, our results suggest that this package of interventions may have contributed to sustained hypertension and diabetes control rates in Pakkred district.


Asunto(s)
COVID-19/prevención & control , Atención a la Salud/organización & administración , Diabetes Mellitus/terapia , Hipertensión/terapia , Monitoreo Ambulatorio de la Presión Arterial/métodos , Agentes Comunitarios de Salud , Continuidad de la Atención al Paciente , Instituciones de Salud , Ambiente de Instituciones de Salud , Accesibilidad a los Servicios de Salud , Humanos , Enfermedades no Transmisibles/terapia , Innovación Organizacional , Equipo de Protección Personal , SARS-CoV-2 , Telemedicina/organización & administración , Tailandia , Ventilación
14.
Health Hum Rights ; 23(1): 119-127, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-34194206

RESUMEN

The inequity in access to COVID-19 vaccines that we are witnessing today is yet another symptom of a pharmaceutical economy that is not fit for purpose. That it was possible to develop multiple COVID-19 vaccines in less than a year, while at the same time fostering extreme inequities, calls for transformative change in the health innovation and access ecosystem. Brought into the spotlight through the AIDS drugs access crisis, challenges in accessing lifesaving medicines and vaccines-because they are either not available or inaccessible due to excessive pricing-are being faced by people all over the world. To appreciate the underlying framing of current access discussions, it is important to understand past trends in global health policies and the thinking behind the institutions and mechanisms that were designed to solve access problems. Contrary to what might be expected, certain types of solutions intrinsically carry the conditions that enable scarcity, rationing, and inequity, and lead us away from ensuring the right to health. Analyzing the root causes of access problems and the political economy that allows them to persist and even become exacerbated is necessary to fix access inequities today and to design better solutions to ensure equitable access to health technologies in the future.


Asunto(s)
Vacunas contra la COVID-19/provisión & distribución , COVID-19 , Accesibilidad a los Servicios de Salud , Derechos Humanos , Humanos
15.
Recenti Prog Med ; 112(7): 499-503, 2021.
Artículo en Italiano | MEDLINE | ID: mdl-34263876

RESUMEN

Access to vaccines against covid-19 is a very topical issue. On the one hand, we are suffering from supply problems and inadequate availability of doses both nationally and internationally. On the other hand, public health needs do not coincide with those of the market economy: the need to vaccinate the entire world population to overcome the pandemic cannot be satisfied due to market rules and limits in production processes. The result is a radical inequality in access to vaccines. We are aware of the delicate balance between health and economy: the latter cannot ignore the former. Also for this reason, the demand for greater equity in access to vaccines is growing: the race for innovation may not be hindered by a targeted relaxation of the rules on intellectual property during a pandemic health emergency.


Asunto(s)
Vacunas contra la COVID-19/provisión & distribución , COVID-19/prevención & control , Desarrollo de Medicamentos , Propiedad Intelectual , Investigación Biomédica/economía , Vacunas contra la COVID-19/economía , Difusión de Innovaciones , Salud Global , Disparidades en Atención de Salud , Humanos , Italia , Evaluación de Necesidades , Patentes como Asunto , Salud Pública , Apoyo a la Investigación como Asunto/economía , Cobertura de Vacunación
17.
J Child Adolesc Psychopharmacol ; 31(7): 457-463, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34283939

RESUMEN

Objectives: Our goal was to develop an open access nationally disseminated online curriculum for use in graduate and continuing medical education on the topic of pediatric telepsychiatry to enhance the uptake of telepsychiatry among child psychiatry training programs and improve access to mental health care for youth and families. Methods: Following Kern's 6-stage model of curriculum development, we identified a core problem, conducted a needs assessment, developed broad goals and measurable objectives in a competency-based model, and developed educational content and methods. The curriculum was reviewed by experts and feedback incorporated. Given the urgent need for such a curriculum due to the COVID-19 pandemic, the curriculum was immediately posted on the American Academy of Child and Adolescent Psychiatry and American Association of Directors of Psychiatric Residency Training websites. Further evaluation will be conducted over the next year. Results: The curriculum covers the six areas of core competence adapted for pediatric telepsychiatry and includes teaching content and resources, evaluation tools, and information about other resources. Conclusion: This online curriculum is available online and provides an important resource and set of standards for pediatric telepsychiatry training. Its online format allows for ongoing revision as the telepsychiatry landscape changes.


Asunto(s)
Psiquiatría del Adolescente/educación , COVID-19 , Psiquiatría Infantil/educación , Curriculum/tendencias , Educación Médica Continua , Educación de Postgrado en Medicina , Acceso a la Información , Adolescente , COVID-19/epidemiología , COVID-19/prevención & control , Niño , Educación/métodos , Educación/organización & administración , Educación Médica Continua/métodos , Educación Médica Continua/organización & administración , Educación de Postgrado en Medicina/métodos , Educación de Postgrado en Medicina/organización & administración , Accesibilidad a los Servicios de Salud , Humanos , Servicios de Salud Mental/normas , Servicios de Salud Mental/tendencias , Innovación Organizacional , Objetivos Organizacionales , SARS-CoV-2 , Telemedicina/métodos
18.
Washington, D.C.; PAHO; 2021-06-15. (PAHO/HSS/SF/21-0007).
en Inglés | PAHO-IRIS | ID: phr-54292

RESUMEN

The PAHO Strategic Fund Annual Report 2020 outlines progress made over the past year in helping ensure access to essential medicines and public health supplies while responding to the COVID-19 pandemic. The report covers various aspects of the Strategic Fund, including benefits offered, participating stakeholders, product offerings, and key initiatives. It also provides useful data, information, statistics, and examples of ways in which the Strategic Fund has facilitated technical cooperation across the Region of the Americas. This report aims to summarize the critical work undertaken by the Strategic Fund during 2020 and offer insight into its operating principles and goals for long-term strengthening and support of health systems in the Region.


Asunto(s)
COVID-19 , Betacoronavirus , Coronavirus , Pandemias , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Equipos y Suministros
19.
Washington, D.C.; OPS; 2021-06-11. (OPS-W/FPL/IM/COVID-19/21-0028).
No convencional en Español | PAHO-IRIS | ID: phr-54270

RESUMEN

En este documento se presenta orientación provisional sobre las mejores prácticas para evaluar la efectividad de las vacunas contra la COVID-19 usando el diseño de estudio observacional. Se examinan las consideraciones esenciales del diseño, el análisis y la interpretación de las evaluaciones de la efectividad de las vacunas contra la COVID-19, dado que se pueden obtener resultados sesgados aun en entornos en los que la exhaustividad y la calidad de los datos son altas. Esta orientación se dirige principalmente a las evaluaciones realizadas en los países de ingresos bajos o medianos, pero la mayoría de los conceptos también son aplicables en entornos de ingresos altos.


Asunto(s)
COVID-19 , Coronavirus , Infecciones por Coronavirus , Betacoronavirus , Vacunas , Enfermedades Prevenibles por Vacunación , Vacunación , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias
20.
Artículo en Inglés | PAHO-IRIS | ID: phr-53910

RESUMEN

[ABSTRACT]. Objective. To examine multiple aspects of the medicines in CARICOM procurement markets, including manufacturer headquarters location, regulatory history, and type (innovator versus generic); the proportion of World Health Organization (WHO) essential medicines; and the most expensive medicines procured. Methods. An analysis of procurement information from selected CARICOM procurers. Four public sector procurement lists were obtained based on public availability or sharing of data from public sector procurers. Analyses were based on parameters available or deduced from these data. Results. The majority of products come from manufacturers headquartered in North America and Europe (63%–67%). The percentage of medicines procured from generic companies is 60%–87%; and 25%–50% of medicines procured are on the WHO Essential Medicines List. Wide price variations exist in the most expensive medicines purchased. Conclusions. The analysis identifies vulnerabilities and opportunities in the procurement situation of CARICOM states, particularly related to quality and rational use of medicines. This analysis represents a baseline that governments and other stakeholders can use in the future.


[RESUMEN]. Objetivo. Revisar los múltiples aspectos de los medicamentos en los mercados de compras y los proveedores de CARICOM, como la ubicación de la sede del fabricante, el historial de regulación, el tipo (patentado versus genérico); la proporción de medicamentos esenciales de la Organización Mundial de la Salud (OMS); y los medicamentos comprados más caros. Métodos. Se analizó información sobre la compra por parte de determinados organismos de CARICOM. La información procedía de cuatro listas de organismos del sector público que realizan las compras, que se consiguieron en función de su disponibilidad pública o de los datos distribuidos por los organismos del sector público que realizan las compras. Los análisis estaban basados en los parámetros disponibles o derivados de estos datos. Resultados. La mayoría de los productos proviene de fabricantes radicados en América del Norte y Europa (entre 63% y 67%). El porcentaje de medicamentos que se compra de empresas genéricas oscila entre 60% y 87%; y de 25% a 50% de los medicamentos que se compran están en la Lista de Medicamentos Esenciales de la OMS. Hay una gran divergencia de precios entre los medicamentos comprados más caros. Conclusiones. En el análisis se han encontrado vulnerabilidades y oportunidades con respecto a la situación de las compras de medicamentos de los Estados de CARICOM, especialmente en cuanto a la calidad y al uso racional de los medicamentos. Este análisis representa una línea de base que los gobiernos u otros interesados directos pueden utilizar en el futuro.


[RESUMO]. Objetivo. Examinar vários aspectos relacionados aos mercados e fornecedores de produtos farmacêuticos da CARICOM, incluindo a localização da sede do laboratório fabricante, histórico regulatório e tipo de produtos (inovadores versus genéricos); proporção de medicamentos adquiridos que constam da relação de medicamentos essenciais da Organização Mundial da Saúde (OMS); e medicamentos mais caros comprados. Métodos. Foi realizada uma análise de informação sobre compras feitas por compradores selecionados da CARICOM. Quatro listas de compras do setor público foram obtidas com informação de acesso público ou compartilhada pelos compradores. As análises foram feitas com base em parâmetros disponíveis ou inferidos a partir dos dados. Resultados. A maioria dos produtos farmacêuticos é proveniente de laboratórios com sedes na América do Norte e Europa (63%–67%). Do total, 60%–87% dos medicamentos adquiridos são de laboratórios de produtos genéricos e 25%–50% constam da relação de medicamentos essenciais da OMS. Existe uma ampla variação nos preços dos medicamentos mais caros comprados. Conclusões. Foram identificadas fragilidades e oportunidades na situação de compras dos países da CARICOM, em particular relacionadas à qualidade dos produtos e ao uso racional dos medicamentos. Esta análise serve de referência a ser usada futuramente pelos governos e outras partes interessadas.


Asunto(s)
Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Comercialización de Medicamentos , Industria Farmacéutica , Economía Farmacéutica , Región del Caribe , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Comercialización de Medicamentos , Industria Farmacéutica , Economía Farmacéutica , Región del Caribe , Acceso a Medicamentos Esenciales y Tecnologías Sanitarias , Comercialización de Medicamentos , Industria Farmacéutica , Economía Farmacéutica , Región del Caribe
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...